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Background: In an era increasingly focused on quality improvement and cost containment, more emphasis is
being placed on wiser utilization of medical care resources. One underutilized resource in early neonatal care is
umbilical cord blood.
Findings: Umbilical cord blood can be utilized for admission laboratory studies in neonates thereby avoiding a
significant phlebotomy event in the first minutes to hours of life. Additionally, umbilical cord blood can also be
safely “transfused” into the neonate via delayed cord clamping or milking of the umbilical cord. This has been
demonstrated to be particularly beneficial in premature infants by decreasing the rate of intraventricular
hemorrhage. Delayed cord clamping has been formally endorsed by a number of medical societies, however it has
not yet been universally adopted by obstetricians and neonatologists.
Conclusions: Both uses of umbilical cord blood for neonatal admission laboratory testing and delayed cord
clamping/milking of the umbilical cord have resulted in decreased transfusion rates as well as other outcomes
reviewed herein.
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In an era increasingly focused on quality improvement
and cost containment, more emphasis is being placed on
wiser utilization of medical care resources. Emphasis has
included aspects such as consistency in the use of
medical interventions, creating evidence-based “bundles”
of care, and process standardization. One underutilized
resource in early neonatal care is the use of umbilical
cord blood. This review will present proposed uses of
this resource in the minutes immediately following deliv-
ery. Specific uses will include utilizing otherwise discarded
umbilical cord blood for all admission laboratory blood
studies, and delayed cord clamping (DCC) or milking of
the umbilical cord (MUC). We will not review the use of
umbilical cord blood for autologous transfusion, umbilical
cord blood banking, or cord blood mesenchymal stem
cells for neonatal therapy in this manuscript.* Correspondence: Patrick.carroll@imail.org
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Drawing all initial laboratory blood tests of very low birth
weight (VLBW) infants using fetal blood in the cord/placenta,
thereby drawing no blood initially on the VLBW neonate
Blood tests are required to care for critically ill neonatal
intensive care unit (NICU) patients, including VLBW in-
fants. VLBW infants typically have greater phlebotomy
blood loss, per kilogram body weight, on the first day of
life than any other day during their hospitalization. In
one study the mean phlebotomy loss on the first day of
life was >10 mL/kg [1]. Laboratory studies performed on
admission can require up to 10 % of an extremely low
birth weight (ELBW) neonate’s circulating blood volume.
Obtaining admission laboratory studies from the other-
wise discarded fetal blood in the umbilical cord or pla-
centa is an alternative to drawing admission laboratory
studies directly from the infant. In the following para-
graphs we will review the data on using umbilical cord
blood for complete blood count (CBC), blood culture,
blood type, antibody screen, newborn metabolic screen-
ing, and genetic testing (Table 1).
In paired-samples of cord blood versus blood drawn at
birth from the neonate, CBC and leukocyte differentialsed Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 List of manuscripts reporting the use of umbilical cord blood for neonatal testing, along with brief description of findings
Laboratory Test Author, year Comments
CBC Hansen, 2005 [5] 113 term infant paired umbilical cord & neonatal samples. High correlation
of WBC, hematocrit, platelets. I:T ratio reported.
Carroll, 2011 [3] 174 preterm infant umbilical cord & neonatal paired samples. High correlation
of WBC, hemoglobin, platelets. False positive thrombocytopenia on 4 cord
samples.
Christensen, 2011 [4] 10 VLBW infant pilot study. No difference in CBC compared to historical
controls.
Beeram, 2012 [2] 200 term and preterm infant umbilical cord & neonatal paired samples. Similar
results between sources. Higher rate of leukopenia in cord samples noted.
Baer, 2013 [10] 91 VLBW infants. No paired samples. Outcome study.
Rotshenker-Olshinka, 2014 [6] 305 term and preterm infant umbilical cord & neonatal paired samples.
Significant correlation between cord and infant CBC.
Blood Culture Polin, 1981 [8] 200 cord blood cultures with 29 paired infant cultures. Cord sterilized with 2 %
tincture of iodine. One septic patient had positive cord and infant culture. Similar
contamination rate between cord samples (2.5 %) and infant samples (3.4 %)
Herson, 1998 [7] 81 term infants, 35 high risk umbilical cord & neonatal paired samples. Placental
vein sterilized with povidone-iodine. 5 mL blood samples from cord obtained.
20 % true positive from cord vs. 3 % true positive from infant cultures of paired
samples.
Hansen, 2005 [5] 113 term infants. Cord sterilized with alcohol. Zero contaminants or true positive
cultures
Christensen, 2011 [4] 10 VLBW infant pilot study. No positive cultures from cases or historical controls.
Beeram, 2012 [2] 200 term and preterm umbilical cord & neonatal paired samples. Cord sterilized
with povidone-iodine and then swabbed with alcohol. 2 contaminants from
cord blood. One contaminant and one pathogen from infant blood.
Baer, 2013 [10] 91 VLBW infants. Prospective outcome study with historical controls.
Rotshenker-Olshinka, 2014 [6] 223 term and preterm infant umbilical cord & neonatal paired samples. Cord
sterilized with chlorhexidine prior to placental delivery. No cases of sepsis.
High contamination rate from both cord sample (12.5 %) and infant sample
(2.5 %).
Blood Type AAP, 2004 [13] Recommends “direct antibody test, blood type, and Rh (D) type on the infant’s
(cord) blood.”
Judd, 2001 [12] Practice guideline for immunohematology. Endorses obtaining blood type from
cord blood or infant blood.
Christensen, 2011 [4] 10 VLBW infant pilot prospective outcome study with historical controls.
Baer, 2013 [10] 91 VLBW infants. Prospective outcome study with historical controls.
Antibody Screen Josephson, 2011 [13] American Association of Blood Banking technical manual. Recommends antibody
testing using plasma or serum from the infant or mother.
Christensen, 2011 [4] 10 VLBW infant pilot study.
Baer, 2013 [10] 91 VLBW infants. No paired samples. Outcome study.
Newborn Metabolic Screen Miller, 2008 [14] CLSI Newborn screening guidelines. Recommends first newborn metabolic test be
obtained upon admission of premature infants.
Christensen, 2011 [4] 10 VLBW infant pilot study.
Baer, 2013 [10] 91 VLBW infants. No paired samples. Outcome study.
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both term and preterm infants [2–6]. In one study there
was a small but notable subset of umbilical cord blood
samples that exhibited a false positive thrombocytopenia
result suggesting that when the platelet count is low
from a CBC drawn from the cord, it should be con-
firmed with direct neonatal draw [3]. Another study re-
ported a higher rate of leukopenia in cord blood samplescompared to neonatal samples [2]. Together these stud-
ies produce compelling evidence that umbilical cord
blood can safely be used in place of direct neonatal
blood draw for a CBC with leukocyte differential. Repeat
direct testing from the neonate may be needed in rare
instances.
Several studies have contrasted blood culture results
when blood is drawn directly from the neonate versus
Carroll and Christensen Maternal Health, Neonatology, and Perinatology  (2015) 1:16 Page 3 of 7otherwise discarded blood from the umbilical cord or
fetal vessels on the placenta [2, 4–8]. It has been noted
that using otherwise discarded fetal blood offers the
benefit of inoculating much higher blood culture
volumes, which increases the sensitivity of the blood
culture [7–9]. Concern is sometimes raised about con-
tamination rates of umbilical cord blood cultures, par-
ticularly after vaginal birth. It is instructive to remember
that the neonate is delivered through the same environ-
ment as the umbilical cord and placenta and care must
be given to adequately sterilize the field prior to obtain-
ing blood cultures, regardless of the anatomical site from
which they are drawn. Several methods have been re-
ported to adequately achieve a sterile cord/placenta in-
cluding use of alcohol, betadine, and tincture of iodine.
Because the surface of the placenta is often wet and
contains depressions between vessels which allow for
pooling of fluid it is beneficial to dry the surface prior to
initiation of sterilization techniques. This procedure may
not be necessary when a cord segment is used for
obtaining a cord blood sample. With compelling data
endorsing DCC or MUC cord, it should be noted that
an adequate cord blood volume can be obtained even
after either DCC or MUC [10].
Determination of the neonatal blood type is frequently
done from umbilical cord blood. Both pediatric [11] and
obstetric [12] literature specifically identify cord blood
as an appropriate source for determining infant blood
type and Rh (D) status. We are unaware of any studies
that have specifically endorsed or refuted this practice
for purposes of neonatal transfusion. It is our opinion
that cord blood can be typed for the purpose of neonatal
transfusion provided the sample is obtained from the
umbilical cord and not from a fetal vein on the placental
surface. Although the blood in the fetal vein on the
placental surface is fetal blood, obtaining a sample in
this manner introduces the possibility of operator error
in which the needle is inserted through the fetal vessel
and into the maternal chorionic villus space with result-
ant aspiration of maternal blood cells. Antibody screen-
ing for the purpose of transfusion of a neonate can also
be performed on umbilical cord blood. The American
Association of Blood Banking states, “initial patient test-
ing must include . . . a screen for unexpected red cell
antibodies, using either plasma or serum from the infant
or mother” [13]. Further studies are required to further
understand the optimal timing of obtaining cord blood
and potential risks of this strategy.
Many states recommend drawing the newborn meta-
bolic screening tests of VLBW infants before antibi-
otics are started, before blood products are transfused,
and before amino acid-containing hyperalimentation
solutions are administered. The Clinical and Laboratory
Standards Institute recommends obtaining the firstnewborn metabolic screen upon admission for prema-
ture infants [14]. Obtaining this first sample from um-
bilical cord blood will result in similar limitations as an
admission sample obtained directly from the infant.
Specifically, despite being reliable for hemoglobinopathies,
GALT and biotinidase enzymes as well as providing base-
line testing for amino acids and acylcarnitines, admission
testing may result in inaccurate TSH, 17-OHP, and cystic
fibrosis (IRT) screening. In both scenarios repeat testing is
required.
To date one pilot study [4] and one multicenter study
[10] have been published reporting neonatal outcomes
as a result of using umbilical cord blood for the admis-
sion laboratory testing in premature infants. The initial
pilot study reported the outcomes of ten patients com-
pared with historical matched controls. A decrease in
erythrocyte transfusions and intraventricular hemorrhage
was observed in the study patients. The larger multicenter
trial enrolled 96 VLBW patients and successfully obtained
umbilical cord blood for admission laboratory testing in
91. Cord blood was successfully obtained in twins, triplets,
following DCC, and in eight of nine infants born at 23–24
weeks gestation. An increase in hemoglobin in the first
12–24 h of life, fewer transfusions per patient, fewer pa-
tients requiring any transfusion, and lower vasopressor
use was observed in study patients. The rate of intraven-
tricular hemorrhage appeared lower but was not statisti-
cally significant. To date no randomized controlled trials
have been reported.
Delayed cord clamping or umbilical cord milking at
preterm delivery
Studies over 45 years ago demonstrated a higher fetal
blood volume and a proportionately lower placental
blood volume in term infants as a result of DCC for up
to 180 s [15]. At term birth, Yao et al. demonstrated a
correlation between the time to cord clamping and
infant blood volume. Using an iodinated albumin dilata-
tion technique Yao demonstrated that delaying cord
clamping by 30, 60, or 180 s increased the infant blood
volume by 6, 14, or 23 mL/kg (Fig. 1). In 2011 Farrar
et al. more clearly defined the volume and duration of
placental transfusion [16]. This study provided a more
detailed understanding of DCC by placing term infants
on a scale with weight measured every 2 s until the um-
bilical cord was clamped. The authors reported a mean
placental transfusion volume of 110 mL (32 mL/kg) fol-
lowing DCC. This volume of placental transfusion was
significantly higher than previously reported. They also
noted that although placental flow appeared to cease at
2 min for most infants it continued for up to 5 min in
some. A recent multicenter trial by Vain et al. demon-
strated similar results using serial weighing of neonates








































Time of cord clamping (seconds) after birth
Fig. 1 Amount of blood “transfused” from the placenta to the fetus during delayed cord clamping at various time intervals compared to early
cord clamping at 5 s. Modified with permission from [41]
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ters, with one reporting 8 mL/kg and another reporting
21 mL/kg following two minutes of DCC. The position
of the infant relative to the mother, in both vaginal and
cesarean delivery, was generally believed to influence the
volume of fetal blood transfused by DCC [18, 19]. How-
ever, the recent randomized controlled trial by Vain
et al. showed equivalent volumes of fetal blood delivered
to the infant by DCC independent of infant position
relative to the mother during DCC in term infants born
by vaginal delivery [17].
For DCC to effectively transfuse placental blood to the
newly delivered neonate fetal blood in the placenta must
continue to transfer into the neonate for a period of
time, i.e., potentially until the umbilical cord is clamped
or cord pulsations cease. If the umbilical vein closes before
the umbilical arteries, the neonate could “hemorrhage”
back into the placenta. To study this, the direction of
blood flow during DCC was evaluated using doppler ultra-
sonography in term infants after vaginal delivery [20]. The
duration of flow in the umbilical vein and both umbilical
arteries varied among the 30 infants in this study. Ninety
percent had venous flow toward the neonate noted imme-
diately after birth, while the remaining 10 % demonstrated
no blood flow. Venous flow continued until the cord was
clamped in 10/30 patients. Venous flow was bidirectional,
with the direction of flow associated with the respiratory
pattern. In some cases retrograde umbilical cord flow was
observed during vigorous crying. It was previously postu-
lated that umbilical arterial flow ceases quickly after deliv-
ery [21]. However, in this series of term infants flow
continued until the cord was clamped in 13/30 patients.
In half of the infants, the umbilical arterial and venousflow ceased at the same time, and in seven of the 30, arter-
ial flow stopped before venous flow. In eight infants, ven-
ous flow stopped before cessation of arterial flow [22].
This study did not quantify flow rate or ratios of flow into
the neonate versus flow from the neonate back to the pla-
centa in cases where both arterial and venous flow contin-
ued. However, it provides important data demonstrating
the variability of placental transfusion among infants and
under certain physiologic conditions such as crying. Simi-
lar studies in premature infants are needed to identify the
direction of flow and factors influencing placental transfu-
sion in this population following both vaginal and caesar-
ean delivery.
Milking of the umbilical cord is another method of
transferring fetal blood from the placenta into the fetus
before clamping and cutting the umbilical cord. This
method offers the potential advantage of being com-
pleted more quickly than DCC. It may also be more en-
thusiastically adopted by obstetricians if they are
uncomfortable holding an extremely premature infant
during DCC without any perceived intervention. Several
studies have used sonography to assess the umbilical
vessel sizes at various gestational ages [23–25]. We used
the reported umbilical vein and umbilical artery diame-
ters to estimate the blood volume within the umbilical
cord of a fetus (Fig. 2). This suggests that a 30 cm seg-
ment of umbilical cord may contain 8 to 28 mL of blood
in a fetus at 23–34 weeks gestation. However, these
values are highly speculative because they represent the
diameter of umbilical vessels in utero rather than ex utero
immediately after delivery. Hosono et al. recently sought
to measure the actual amount of blood delivered by MUC

















































Gestational Age (completed weeks)
Weissman et al. Barbieriet al. Togni et al.
Fig. 2 In-utero volume of blood contained within a 30 cm segment of umbilical cord at various gestational ages. Volumes were calculated from
umbilical vein and artery diameters reported in the obstetric literature [23–25]
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blood. Although this study may have overestimated the
cord blood volume since the proximal and distal ends of
the cord were not clamped simultaneously, it is the first
study to report blood volume in a specific length of umbil-
ical cord of preterm infants and thus provides valuable
information.
Until recently, current practice was ICC following
delivery of a premature infant. Over the past several
years a number of organizations including the World
Health Organization, Royal College of Obstetricians &
Gynaecologists, and American College of Obstetricians &
Gynecologists have formally endorsed DCC as standard of
care [27–29]. The World Health Organization strongly
recommends waiting at least one minute after birth before
clamping the umbilical cord in term or preterm babies
who do not require positive-pressure ventilation. The
Royal College of Obstetricians & Gynaecologists supports
DCC in healthy term infants with the infant not elevated
higher than the mother’s chest prior to umbilical cord
clamping. Their recommendations for preterm births sug-
gest potential benefit by DCC and recommend develop-
ment of strategies to provide initial neonatal care and
resuscitation at the woman’s bedside with the cord intact.
MUC is mentioned as an alternative but not formally
endorsed as routine practice. The American College of
Obstetricians & Gynecologists support DCC in preterm
infants when feasible.
Premature infant brains are sensitive to fluctuations in
blood pressure, particularly hypotension due to poor
cerebral autoregulation [30]. Maintaining stable blood
pressure may be a factor in limiting intraventricular
hemorrhage [31]. Recently, Katheria et al. demonstrated
improved superior vena cava blood flow and rightventricular output, both markers of systemic blood flow,
in preterm infants following MUC compared to ICC
[32]. Additionally, the diastolic and mean blood pressure
within the first six hours of life was increased in the
MUC group. This finding is consistent with previous
studies on MUC [33, 34].
Recently benefits of DCC versus ICC have been
assessed in premature infants. By 2004 at least seven
randomized controlled trials compared ICC with DCC
of preterm infants. Although the definition for DCC var-
ied from 30 to 120 s, DCC was associated with higher
hematocrits, fewer transfusions, and less intraventricular
hemorrhage [35]. While some investigators were study-
ing DCC others were testing MUC as a potentially more
rapid alternative [33, 34]. In 2012, a Cochrane review
included 15 randomized controlled trials on DCC up to
180 s or MUC, versus ICC [36]. The summary findings
included 39 % fewer erythrocyte transfusions for anemia
(7 studies), 41 % fewer patients with intraventricular
hemorrhage (12 studies), and 38 % fewer patients with
necrotizing enterocolitis (four studies). Although there
was a 37 % decrease in death reported, this finding was
not statistically significant. However, when analysis was
limited to infants less than 32 weeks gestation [37], im-
proved mortality rate was statistically significant. Backes
et al. demonstrated that among infants <32 weeks
undergoing either DCC or MUC, the mortality rate was
decreased by 58 % (8 studies) [37]. With nearly 4 million
births in the United States [38] and 1.93 % born before
32 weeks gestation [39] this technique could result in
4,500 lives saved annually in the United States with an
even greater impact when worldwide births are consid-
ered. A lower mortality rate was independently reported
in a manuscript of a quality improvement initiative
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<30 weeks gestation [40]. Compared to historical con-
trols the rate of survival after MUC increased from
84 to 94 % in neonates less than 30 weeks gestation,
and increased from 76 to 91 % among infants less
than 27 weeks gestation. Researchers continue to in-
vestigate the optimal duration of DCC, the best
methods for MUC, and the best rational for using
one versus the other technique in various clinical
situations.
Conclusion
Umbilical cord blood may be the most valuable underu-
tilized resource in the care of premature neonates.
Utilization of umbilical cord blood for admission labora-
tory testing of neonates is a promising new practice that
has been shown to improve neonatal outcomes. While
DCC and MUC have been formally endorsed by a num-
ber of professional organizations they have not yet been
universally adopted by obstetricians and neonatologists.
Full implementation of this practice is therefore an im-
portant step in better utilization of umbilical cord blood
in improving the outcomes of premature neonates.
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